Fig. 2.
Comparison of the prognosis between HeFH patients in the lipoprotein apheresis continuation group and those in the lipoprotein apheresis discontinuation group before the PCSK9 antibody was launched33)
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.